Webinar invitation: health and wellbeing series

GESB, in partnership with AIA Australia, invites you to join an insightful webinar on the ongoing popularity of GLP-1 medications, such as Ozempic. You’ll learn about the potential benefits, risks and wider impact on conversations about health.
Ozempic Boom webinar
Date: 11 August 2026
Time: 10.30 – 11am AWST
Where: online via Microsoft Teams
An access link will be provided closer to the event.
About the event
This webinar is presented by AIA and features guest speaker Associate Professor Neale Cohen from the Baker Heart and Diabetes Institute.
Get insights on the ongoing popularity of GLP-1 medications, including:
- What’s driving demand
- The potential benefits, risks and wider impacts
- What this trend could mean for individuals and conversations about health
You don’t have to be a GESB member to attend.
Why this matters
GLP-1 medications are prescription drugs used to regulate appetite and blood sugar levels. They are widely discussed in the media and among the public.
GESB and AIA are partnering to help attendees gain a better understanding of the ongoing interest in these medications and feel more empowered with the latest health information.
After you register
AIA will email a registration confirmation, and a webinar access link will be provided closer to the event by email.
If you register but can’t attend on the day, a recording of the webinar will be made available on AIA's webinar page.
About the health and wellbeing webinar series
As the default super fund for most of the WA public sector, GESB’s purpose is to support its members throughout their working life and into retirement - and that means more than helping them grow their super.
This webinar is part of a series of webinars designed to help support people's everyday health and wellbeing, with expert guidance and tools for every stage across work and life.
Thank you for printing this page. Remember to come back to gesb.wa.gov.au for the latest information as our content is updated regularly. This information is correct as at 03 August 2026.